Regenxbio RGNX Operating margin

Operating margin at other companies

Regeneron PharmaceuticalsREGN

24.7%-2.3pp

BioMarin PharmaceuticalsBMRN

19.9%+7.2pp

EyePoint, Inc.EYPT

-11,365.2%-11,754pp

Ultragenyx PharmaceuticalRARE

-73.6%-7.3pp

4D Molecular TherapeuticsFDMT

-220.1%-110pp

Viridian Therapeutics, Inc.VRDN

-569.7%-284pp

FAQ

What is Regenxbio's operating margin?

Regenxbio (RGNX) reported operating margin of -94.1% in Q2 2026.

How has Regenxbio's operating margin changed year-over-year?

Regenxbio's operating margin increased by 11.0% year-over-year, from -105.7% to -94.1%.

What is the long-term trend for Regenxbio's operating margin?

Over 5 years (2020 to 2025), Regenxbio's operating margin has grown at a 4.2% compound annual growth rate (CAGR), from -77.1% to -94.6%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.